Schonfeld Strategic Advisors LLC Blueprint Medicines Corp Transaction History

Schonfeld Strategic Advisors LLC

$12.5 Billion
Q2 2025

A detailed history of Schonfeld Strategic Advisors LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 16,228 shares of BPMC stock, worth $2.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

16,228

Previous 45,300 64.18%

Holding current value

$2.1 Million

Previous $4.01 Million 48.12%

% of portfolio

0.02%

Previous 0.03%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$79.22 - $128.4 $2.3 Million - $3.73 Million	-29,072 Reduced 64.18%	16,228 $2.08 Million
Q1 2025 May 15, 2025	BUY	$86.69 - $115.63 $2.78 Million - $3.71 Million	32,100 Added 243.18%	45,300 $4.01 Million
Q4 2024 Feb 14, 2025	SELL	$82.48 - $101.39 $3.81 Million - $4.68 Million	-46,158 Reduced 77.76%	13,200 $1.15 Million
Q3 2024 Nov 14, 2024	BUY	$84.1 - $120.5 $4.66 Million - $6.68 Million	55,408 Added 1402.73%	59,358 $5.49 Million
Q2 2024 Aug 14, 2024	BUY	$85.18 - $108.78 $336,461 - $429,681	3,950 New	3,950 $425,000
Q1 2023 May 15, 2023	BUY	$37.97 - $50.0 $2.64 Million - $3.48 Million	69,629 New	69,629 $3.13 Million
Q3 2022 Nov 14, 2022	BUY	$49.93 - $77.7 $1.32 Million - $2.06 Million	26,484 New	26,484 $1.74 Million
Q4 2021 Feb 14, 2022	SELL	$94.25 - $115.99 $1.87 Million - $2.3 Million	-19,818 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$80.98 - $109.47 $1.24 Million - $1.68 Million	15,318 Added 340.4%	19,818 $2.04 Million
Q2 2021 Aug 16, 2021	BUY	$82.78 - $101.0 $372,510 - $454,500	4,500 New	4,500 $395,000
Q1 2021 May 17, 2021	SELL	$90.71 - $108.28 $2.46 Million - $2.94 Million	-27,137 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$92.08 - $124.48 $1.91 Million - $2.58 Million	20,722 Added 323.02%	27,137 $3.04 Million
Q3 2020 Nov 16, 2020	BUY	$66.45 - $92.7 $426,276 - $594,670	6,415 New	6,415 $595,000
Q1 2020 May 15, 2020	SELL	$48.11 - $82.22 $147,890 - $252,744	-3,074 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$66.73 - $82.59 $2.05 Million - $2.54 Million	-30,726 Reduced 90.91%	3,074 $246,000
Q3 2019 Nov 14, 2019	SELL	$72.9 - $101.41 $8 Million - $11.1 Million	-109,700 Reduced 76.45%	33,800 $2.48 Million
Q2 2019 Aug 14, 2019	BUY	$73.54 - $97.8 $1.58 Million - $2.1 Million	21,500 Added 17.62%	143,500 $13.5 Million
Q1 2019 May 15, 2019	BUY	$48.7 - $86.6 $5.94 Million - $10.6 Million	122,000 New	122,000 $9.77 Million
Q1 2018 May 15, 2018	SELL	$73.28 - $102.95 $995,728 - $1.4 Million	-13,588 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$62.91 - $88.32 $854,821 - $1.2 Million	13,588	13,588 $1.02 Million

Others Institutions Holding BPMC

# of Institutions

390

Shares Held

66.9M

Call Options Held

973K

Put Options Held

1.54M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $7.73B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC Blueprint Medicines Corp Transaction History